Rokos Capital Management (UK)’s DexCom DXCM Stock Holding History

Rokos Capital Management (UK)’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,591	Closed	-$645K	–	163
2025 Q3	$645K	Buy	+9,591	New	+$759K	﹤0.01%	154

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Rokos Capital Management (UK)'s DXCM Position: Q4 2025 in Review

Rokos Capital Management (UK) sold out of DexCom (DXCM) in Q4 2025, closing a stake of 9,591 shares — an estimated $645K sold.

Rokos Capital Management (UK) first reported a position in DXCM in Q3 2025 and held it in 1 quarter. The position peaked at $645K in Q3 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Rokos Capital Management (UK) reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Rokos Capital Management (UK) sold 9,591 DexCom shares in Q4 2025, an estimated $645K.
Rokos Capital Management (UK) first reported a position in DexCom in Q3 2025 and held it in 1 quarter.
Rokos Capital Management (UK)'s DexCom position peaked at $645K in Q3 2025.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Rokos Capital Management (UK)'s 13F filing for Q4 2025, filed 13 Feb 2026.